What is the address of PHIL IMPLANTS?

The registered office of PHIL IMPLANTS is located at Libramont,Rue Haynol 27, 6800 Libramont-Chevigny.

Is PHIL IMPLANTS still active?

Yes. According to the CBE (30 October 2026) PHIL IMPLANTS is active, legal situation “Normale toestand”, started on 18 January 2008.

Is PHIL IMPLANTS registered on Peppol?

Yes, PHIL IMPLANTS is registered on the Peppol network with ID 0208:0895021374.

What is the enterprise number of PHIL IMPLANTS?

The enterprise number of PHIL IMPLANTS is BE0895021374.

When was PHIL IMPLANTS founded?

PHIL IMPLANTS was founded on 18 January 2008.

Who are the directors of PHIL IMPLANTS?

According to the 2025 annual accounts, the directors of PHIL IMPLANTS are: Philippe PESTIEAU, Philippe THUMILAIRE.

Is PHIL IMPLANTS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 January 2008; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHIL IMPLANTS make in 2025?

PHIL IMPLANTS posted a profit after taxes of € 5,171 in financial year 2025.

What is the revenue of PHIL IMPLANTS?

In its most recent annual accounts (2025), PHIL IMPLANTS reported revenue of € 165,960.

PHIL IMPLANTS (Private Limited) - Libramont-Chevigny

Dossier PHIL IMPLANTS, printed on 30 October 2026 from databakkes.be/en/0895021374/phil-implants. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHIL IMPLANTS from Libramont-Chevigny, company number BE0895021374, closed financial year 2025 with a result of € 5,171 after tax. For that financial year PHIL IMPLANTS recorded revenue of € 165,960 and equity of € 31,233. Compared with financial year 2024, the result moved from € 8,330 to € 5,171. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 18, 2026.

What it is worth Growing

€ 31,233

▲ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 5,171

▼ 38% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 41,960

▲ 24% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 25,033.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5,168

▲ € 3,918 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,212

▲ 99% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	-	-	-	€ 165,960 Revenue 2025: € 165,960 First fiscal year in the series
Gross margin	€ 46,718 Gross margin 2022: € 46,718 First fiscal year in the series	€ 15,218 Gross margin 2023: € 15,218 ▼ 67% vs 2022 (€ 46,718) Unfavourable step	€ 13,681 Gross margin 2024: € 13,681 ▼ 10% vs 2023 (€ 15,218) Unfavourable step	€ 11,177 Gross margin 2025: € 11,177 ▼ 18% vs 2024 (€ 13,681) Unfavourable step	▼ 18%
Profit after taxes	€ 35,385 Profit after taxes 2022: € 35,385 First fiscal year in the series	€ 10,281 Profit after taxes 2023: € 10,281 ▼ 71% vs 2022 (€ 35,385) Unfavourable step	€ 8,330 Profit after taxes 2024: € 8,330 ▼ 19% vs 2023 (€ 10,281) Unfavourable step	€ 5,171 Profit after taxes 2025: € 5,171 ▼ 38% vs 2024 (€ 8,330) Unfavourable step	▼ 38%
Equity	€ 34,451 Equity 2022: € 34,451 First fiscal year in the series	€ 29,732 Equity 2023: € 29,732 ▼ 14% vs 2022 (€ 34,451) Unfavourable step	€ 26,062 Equity 2024: € 26,062 ▼ 12% vs 2023 (€ 29,732) Unfavourable step	€ 31,233 Equity 2025: € 31,233 ▲ 20% vs 2024 (€ 26,062) Favourable step	▲ 20%
Total debts	€ 49,882 Total debts 2022: € 49,882 First fiscal year in the series	€ 23,771 Total debts 2023: € 23,771 ▼ 52% vs 2022 (€ 49,882) Favourable step	€ 30,148 Total debts 2024: € 30,148 ▲ 27% vs 2023 (€ 23,771) Unfavourable step	€ 25,158 Total debts 2025: € 25,158 ▼ 17% vs 2024 (€ 30,148) Favourable step	▼ 17%
Cash	€ 54,146 Cash 2022: € 54,146 First fiscal year in the series	€ 19,681 Cash 2023: € 19,681 ▼ 64% vs 2022 (€ 54,146) Unfavourable step	€ 33,925 Cash 2024: € 33,925 ▲ 72% vs 2023 (€ 19,681) Favourable step	€ 41,960 Cash 2025: € 41,960 ▲ 24% vs 2024 (€ 33,925) Favourable step	▲ 24%
Retained profit	€ 28,251 Retained profit 2022: € 28,251 First fiscal year in the series	€ 23,532 Retained profit 2023: € 23,532 ▼ 17% vs 2022 (€ 28,251) Unfavourable step	€ 19,862 Retained profit 2024: € 19,862 ▼ 16% vs 2023 (€ 23,532) Unfavourable step	€ 25,033 Retained profit 2025: € 25,033 ▲ 26% vs 2024 (€ 19,862) Favourable step	▲ 26%
Dividend	€ 20,000 Dividend 2022: € 20,000 First fiscal year in the series	€ 15,000 Dividend 2023: € 15,000 ▼ 25% vs 2022 (€ 20,000) Unchanged	€ 12,000 Dividend 2024: € 12,000 ▼ 20% vs 2023 (€ 15,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 12,000) Unchanged	▼ 100%
Balance sheet total	€ 84,333 Balance sheet total 2022: € 84,333 First fiscal year in the series	€ 53,503 Balance sheet total 2023: € 53,503 ▼ 37% vs 2022 (€ 84,333) Unchanged	€ 56,210 Balance sheet total 2024: € 56,210 ▲ 5% vs 2023 (€ 53,503) Unchanged	€ 56,391 Balance sheet total 2025: € 56,391 Unchanged (€ 56,210) Unchanged

Key figures of PHIL IMPLANTS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHIL IMPLANTS?

What happened at PHIL IMPLANTS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 18, 2026 New annual accounts for financial year 2025: profit of € 5,171 (▼ 38% vs 2024). Source: NBB ↗
Jan 18, 2008 Start of the company according to the CBE. KBO

In short

From € 35,385 profit in 2022 to € 5,171 profit in 2025.

Paid € 18,327 in corporate taxes since 2022.

Best year ever: 2022, with € 35,385 profit.

Paid out € 47,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Philippe PESTIEAU Philippe THUMILAIRE

PHIL IMPLANTS

PHILIPPE THUMILAIRE

THUMILAIRE DENTAIRE

Behind PHIL IMPLANTS are Philippe PESTIEAU and Philippe THUMILAIRE. Philippe THUMILAIRE is also behind PHILIPPE THUMILAIRE and THUMILAIRE DENTAIRE.

Directors

According to the 2025 annual accounts

Philippe PESTIEAU

Manager

Philippe THUMILAIRE

Manager

Also active at: PHILIPPE THUMILAIRE, THUMILAIRE DENTAIRE

Establishments

Establishment units

Physical locations of this company

Registered office

Libramont,Rue Haynol 27

6800 Libramont-Chevigny

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

THUMILAIRE DENTAIRE same network

€ 120,810 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0895.021.374
VAT number: BE 0895.021.374
Registered office: Libramont,Rue Haynol 27, 6800 Libramont-Chevigny
Names & denominations: PHIL IMPLANTS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 18 January 2008
Peppol: Active · Active since 3 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗